Karyopharm Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.91 0.58 Dec/2025
Abbott 1.92 0.15 Dec/2025
Amgen 2.95 0.38 Dec/2025
AstraZeneca USD 1.74 0.4 Dec/2025
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 0.22 0.04 Dec/2025
Eli Lilly 0.58 0.16 Dec/2025
Enanta Pharmaceuticals 0 0 Mar/2025
GlaxoSmithKline 4.57 1.52 Dec/2025
J&J 2.5 0.32 Dec/2025
Karyopharm Therapeutics 0 0 Mar/2025
Merck 3.12 0.74 Dec/2025
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.31 0.06 Sep/2025
Novartis 3.12 0.26 Sep/2025
Pfizer 6.91 0.33 Dec/2025
Regeneron Pharmaceuticals 0.46 0.01 Dec/2025
Roche Holding 2.96 0.8 Dec/2025
Sangamo BioSciences 0 0 Mar/2025
Takeda 4.08 0.46 Dec/2025